查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1949474

微生物組樣本製備技術市場－全球產業規模、佔有率、趨勢、機會和預測：按產品、工作流程、應用、疾病類型、最終用戶、地區和競爭格局分類，2021-2031年

Microbiome Sample Preparation Technology Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Workflow, By Application, By Disease Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球微生物組樣本製備技術市場預計將從 2025 年的 2.5 億美元成長到 2031 年的 3.7 億美元，複合年成長率為 6.75%。

此領域涵蓋用於從各種生物基質中分離、純化和穩定高品質微生物核酸的專用試劑、試劑盒和自動化設備，以便進行後續分析。推動該領域發展的主要因素是生活方式相關慢性疾病發病率的上升以及對需要精確微生物分析的個人化療法的需求日益成長。此外，加強產業合作也提升了研究能力。例如，皮斯托亞聯盟（Pistoia Alliance）在2024年報告稱，已與200多個成員機構在競爭前計劃方面開展合作，包括構建微生物組介導的藥物代謝資料庫，以加速治療方法的發現。

市場概覽
預測期 2027-2031
市場規模：2025年 2.5億美元
市場規模：2031年 3.7億美元
複合年成長率：2026-2031年 6.75%
成長最快的細分市場 消耗品
最大的市場 北美洲

儘管呈上升趨勢，但由於缺乏普遍標準化的通訊協定採集和處理方案，該行業仍面臨許多挑戰。微生物樣本固有的多樣性常常導致不同研究間數據不一致和提取偏差，從而喪失了監管檢驗和商業性擴充性所需的可重複性。

市場促進因素

微生物組研究資金籌措和投資的激增是全球微生物組樣本製備技術市場的關鍵催化劑。隨著腸道健康與整體健康之間聯繫的日益清晰，越來越多的資本投入到致力於標準化工作流程和開發新治療方法的生物技術公司。這些資金支持使公司能夠最佳化樣本採集和提取過程，並確保產生臨床檢驗所需的高精度數據。這一趨勢在Biohm Technologies公司尤為明顯，該公司於2025年4月完成B輪融資，籌集了452萬美元，並宣布擴大其微生物組數據和技術產品範圍。這正在加速開發能夠處理複雜基質的先進試劑盒。

此外，次世代定序技術的突破性進展催生了對能夠應對現代平台高通量和高靈敏度要求的上游工程解決方案的需求，從而加速了市場擴張。隨著定序工具成本效益和數據產出能力的提升，處理瓶頸問題也隨之出現，而自動化、高效的樣品製備系統對於克服這些瓶頸至關重要。主要企業的強勁財務業績印證了這一趨勢。牛津奈米孔科技公司（Oxford Nanopore Technologies）公佈的截至2025年6月的會計年度中期業績顯示，剔除外匯波動影響後，其營收成長了28.0%；Illumina公司公佈的截至2025年10月的會計年度季度營收為10.8億美元。這些數據凸顯了可靠的樣品製備在支持不斷發展的基因組分析生態系統中發揮的關鍵作用。

市場挑戰

全球微生物組樣本製備技術市場面臨的主要障礙是樣本採集和調查方法缺乏普遍統一的標準。這種不一致性造成了嚴重的瓶頸，損害了資料的完整性和可重複性。當不同的實驗室採用不同的萃取試劑盒和穩定化技術時，最終得到的微生物譜往往有顯著差異，難以區分真實的生物訊號和技術誤差。根據皮斯托亞聯盟 (Pistoia Alliance) 2024 年的一項調查，48% 的生命科學專業人士認為，缺乏元資料標準化是有效利用實驗數據進行研發的主要障礙，阻礙了檢驗臨床生物標記所需的跨研究比較。

因此，這種波動性阻礙了監管核准和商業化進程，並限制了市場發展。監管機構需要可靠且可重複的數據來確認基於微生物組的診斷和治療方法的安全性和有效性，但由於缺乏統一的通訊協定，製造商難以證明其一致性。這種不確定性抑制了投資意願，減緩了樣本製備技術在臨床環境中的應用，並最終限制了整體市場收入潛力。

市場趨勢

針對低生物量環境的專用萃取解決方案的開發正在改變市場格局，其解決的是處理微生物含量極低的樣本（例如皮膚和血液）所面臨的挑戰。傳統試劑盒通常面臨這些基質中宿主DNA與微生物DNA比例過高的難題，因此需要高靈敏度和最佳化的通訊協定來確保獲得高品質的數據。這項技術需求正在推動旨在提高提取效率的策略合作。例如，2024年11月，凱傑公司（Qiagen）和麥基爾大學宣布合作，共同開發專門針對低生物量樣本的方法，旨在加強其在價值18億美元的北美微生物組研究領域的影響力。

同時，微流體技術在單細胞微生物組製備中的應用日益廣泛，旨在揭示傳統批量定序中常被忽略的異質性。透過在微流體液滴中分離單一細菌，這些平台能夠精確繪製複雜群落中菌株特異性基因表現和代謝功能圖。正如我們在2024年12月發表的關於新興技術的報導中所強調的，M20 Genomics公司透露，其VITA單細胞轉錄組平台已在全球範圍內處理了超過7000個微生物樣本。這表明這些工作流程具有擴充性和快速應用性，能夠有效區分不同物種的功能差異。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球微生物組樣本製備技術市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品分類（設備、耗材）
    • 工作流程分解（樣品萃取/分離、樣品定量、品管、碎片化、樣品製備、目標濃縮、文庫定量、混合）
    • 應用特定定序（DNA定序、全基因測序、RNA定序、甲基化定序、宏總體基因體學、單細胞定序等）
    • 疾病類型（自體免疫疾病、癌症、消化系統疾病、其他）
    • 依最終用戶（製藥/生物技術、診斷檢查室、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美微生物組樣本製備技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲微生物組樣本製備技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區微生物組樣本製備技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲微生物組樣本製備技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美微生物組樣本製備技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球微生物組樣本製備技術市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific
  • Zymo Research
  • Molzym
  • Omega Bio-tek
  • Promega
  • PerkinElmer
  • New England Biolabs
  • Kapa Biosystems

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 26749

The Global Microbiome Sample Preparation Technology Market is projected to expand from USD 0.25 Billion in 2025 to USD 0.37 Billion by 2031, registering a CAGR of 6.75%. This sector encompasses specialized reagents, kits, and automated instrumentation designed to isolate, purify, and stabilize high-quality microbial nucleic acids from various biological matrices for subsequent analysis. Growth is primarily propelled by the rising incidence of chronic lifestyle-related conditions and the growing need for personalized medical treatments that require accurate microbial profiling. Furthermore, enhanced industrial cooperation is strengthening research capacities; for instance, the Pistoia Alliance reported in 2024 that it coordinated with over 200 member organizations on pre-competitive initiatives, such as creating a microbiome-mediated drug metabolism database to facilitate therapeutic discovery.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 0.25 Billion
Market Size 2031USD 0.37 Billion
CAGR 2026-20316.75%
Fastest Growing SegmentConsumables
Largest MarketNorth America

Despite this upward trend, the industry faces a substantial hurdle due to the absence of universally standardized protocols for sample collection and processing. The intrinsic diversity of microbial samples frequently leads to inconsistent data and extraction biases across different studies, which compromises the reproducibility needed for regulatory validation and commercial scalability.

Market Driver

The surge in funding and investment for microbiome research serves as a crucial catalyst for the Global Microbiome Sample Preparation Technology Market. As the connection between gut health and systemic well-being becomes clearer, capital is increasingly directed toward biotechnology firms aiming to standardize workflows and create new therapeutic formulations. This financial support enables companies to optimize sample collection and extraction procedures, ensuring the generation of high-fidelity data necessary for clinical validation. This trend is exemplified by Biohm Technologies, which announced in April 2025 that it had raised $4.52 million in a Series B round to broaden its microbiome data and technology offerings, thereby fueling the development of advanced kits capable of managing complex matrices.

Additionally, technological breakthroughs in Next-Generation Sequencing are accelerating market expansion by creating a need for upstream solutions that align with the high throughput and sensitivity of contemporary platforms. As sequencing tools evolve to offer lower costs and higher data yields, they create processing bottlenecks that can only be alleviated by automated, efficient sample preparation systems. The strong financial performance of key players highlights this dynamic; Oxford Nanopore Technologies reported a 28.0% constant currency revenue increase in its interim results for the period ending June 2025, while Illumina posted quarterly revenue of $1.08 billion in October 2025. These figures underscore the essential role of reliable sample preparation in supporting the growing genomic profiling ecosystem.

Market Challenge

The primary obstacle facing the Global Microbiome Sample Preparation Technology Market is the lack of universal standardization regarding sample collection and processing methodologies. This inconsistency creates a severe bottleneck by undermining data integrity and reproducibility; when laboratories employ different extraction kits or stabilization methods, the resulting microbial profiles often vary significantly, making it difficult to differentiate between genuine biological signals and technical artifacts. According to a 2024 survey by the Pistoia Alliance, 48% of life science experts identified the lack of metadata standardization as a major impediment to the effective use of experimental data in research and development, preventing the cross-study comparisons required to validate clinical biomarkers.

Consequently, this variability impedes market progress by stalling regulatory approvals and commercialization efforts. Regulatory authorities demand robust, reproducible data to confirm the safety and efficacy of microbiome-based diagnostics and treatments, yet manufacturers struggle to prove this consistency without unified protocols. This uncertainty discourages investment and retards the adoption of sample preparation technologies within clinical environments, ultimately restricting the market's overall revenue potential.

Market Trends

The development of specialized extraction solutions for low-biomass environments is transforming the market by resolving difficulties associated with processing samples containing minimal microbial content, such as skin and blood. Conventional kits often face challenges with high host-to-microbial DNA ratios in these matrices, creating a need for sensitive, optimized protocols to secure high-quality data. This technical requirement is spurring strategic partnerships focused on improving extraction efficiency; for example, in November 2024, Qiagen and McGill University announced a collaboration to co-develop methods tailored for low-biomass samples, aiming to better address the needs of the $1.8 billion North American microbiome research sector.

Concurrently, the utilization of microfluidic technologies for single-cell microbiome preparation is increasing as researchers strive to uncover heterogeneity often missed by traditional bulk sequencing. By isolating individual bacteria within microfluidic droplets, these platforms facilitate the precise mapping of strain-specific gene expression and metabolic functions within complex communities. As highlighted in a December 2024 article on emerging technologies, M20 Genomics revealed that its VITA single-cell transcriptome platform has processed over 7,000 microbial samples worldwide, illustrating the scalability and rapid uptake of these workflows to distinguish functional variations across diverse species.

Key Market Players

  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific
  • Zymo Research
  • Molzym
  • Omega Bio-tek
  • Promega
  • PerkinElmer
  • New England Biolabs
  • Kapa Biosystems

Report Scope

In this report, the Global Microbiome Sample Preparation Technology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microbiome Sample Preparation Technology Market, By Product

  • Instruments
  • Consumables

Microbiome Sample Preparation Technology Market, By Workflow

  • Sample Extraction/Isolation
  • Sample Quantification
  • Quality Control
  • Fragmentation
  • Library Preparation
  • Target Enrichment
  • Library Quantification
  • Pooling

Microbiome Sample Preparation Technology Market, By Application

  • DNA Sequencing
  • Whole-Genome Sequencing
  • RNA Sequencing
  • Methylation Sequencing
  • Metagenomics
  • Single Cell Sequencing
  • Others

Microbiome Sample Preparation Technology Market, By Disease Type

  • Autoimmune Disorder
  • Cancer
  • Gastrointestinal Disorders
  • Others

Microbiome Sample Preparation Technology Market, By End User

  • Pharmaceutical & Biotechnology
  • Diagnostic Labs
  • Others

Microbiome Sample Preparation Technology Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Microbiome Sample Preparation Technology Market.

Available Customizations:

Global Microbiome Sample Preparation Technology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microbiome Sample Preparation Technology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Instruments, Consumables)
    • 5.2.2. By Workflow (Sample Extraction/Isolation, Sample Quantification, Quality Control, Fragmentation, Library Preparation, Target Enrichment, Library Quantification, Pooling)
    • 5.2.3. By Application (DNA Sequencing, Whole-Genome Sequencing, RNA Sequencing, Methylation Sequencing, Metagenomics, Single Cell Sequencing, Others)
    • 5.2.4. By Disease Type (Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Others)
    • 5.2.5. By End User (Pharmaceutical & Biotechnology, Diagnostic Labs, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2025)
  • 5.3. Market Map

6. North America Microbiome Sample Preparation Technology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Workflow
    • 6.2.3. By Application
    • 6.2.4. By Disease Type
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Microbiome Sample Preparation Technology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Workflow
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By Disease Type
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Microbiome Sample Preparation Technology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Workflow
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By Disease Type
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Microbiome Sample Preparation Technology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Workflow
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By Disease Type
        • 6.3.3.2.5. By End User

7. Europe Microbiome Sample Preparation Technology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Workflow
    • 7.2.3. By Application
    • 7.2.4. By Disease Type
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Microbiome Sample Preparation Technology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Workflow
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By Disease Type
        • 7.3.1.2.5. By End User
    • 7.3.2. France Microbiome Sample Preparation Technology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Workflow
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By Disease Type
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Microbiome Sample Preparation Technology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Workflow
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By Disease Type
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Microbiome Sample Preparation Technology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Workflow
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By Disease Type
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Microbiome Sample Preparation Technology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Workflow
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By Disease Type
        • 7.3.5.2.5. By End User

8. Asia Pacific Microbiome Sample Preparation Technology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Workflow
    • 8.2.3. By Application
    • 8.2.4. By Disease Type
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Microbiome Sample Preparation Technology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Workflow
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By Disease Type
        • 8.3.1.2.5. By End User
    • 8.3.2. India Microbiome Sample Preparation Technology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Workflow
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By Disease Type
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Microbiome Sample Preparation Technology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Workflow
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By Disease Type
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Microbiome Sample Preparation Technology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Workflow
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By Disease Type
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Microbiome Sample Preparation Technology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Workflow
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By Disease Type
        • 8.3.5.2.5. By End User

9. Middle East & Africa Microbiome Sample Preparation Technology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Workflow
    • 9.2.3. By Application
    • 9.2.4. By Disease Type
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Microbiome Sample Preparation Technology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Workflow
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By Disease Type
        • 9.3.1.2.5. By End User
    • 9.3.2. UAE Microbiome Sample Preparation Technology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Workflow
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By Disease Type
        • 9.3.2.2.5. By End User
    • 9.3.3. South Africa Microbiome Sample Preparation Technology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Workflow
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By Disease Type
        • 9.3.3.2.5. By End User

10. South America Microbiome Sample Preparation Technology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Workflow
    • 10.2.3. By Application
    • 10.2.4. By Disease Type
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Microbiome Sample Preparation Technology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Workflow
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By Disease Type
        • 10.3.1.2.5. By End User
    • 10.3.2. Colombia Microbiome Sample Preparation Technology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Workflow
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By Disease Type
        • 10.3.2.2.5. By End User
    • 10.3.3. Argentina Microbiome Sample Preparation Technology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Workflow
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By Disease Type
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Microbiome Sample Preparation Technology Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Illumina
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. QIAGEN
  • 15.3. Thermo Fisher Scientific
  • 15.4. Zymo Research
  • 15.5. Molzym
  • 15.6. Omega Bio-tek
  • 15.7. Promega
  • 15.8. PerkinElmer
  • 15.9. New England Biolabs
  • 15.10. Kapa Biosystems

16. Strategic Recommendations

17. About Us & Disclaimer